Send feedback

INTS1 p.Glu1742Lys

c.5224G>A · rs371534075 · VCV1064556

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.8262 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00591%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies

Computational evidence

Protein change
AlphaMissense0.8262likely pathogenic
REVEL0.557indeterminate
SaProtLLR -10.59damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 1.6, phastCons 1
Regional constrainto/e 1.09unconstrained · MANE · 12 kb · p 0.001 · regional, not allelic
Overall
CADD26.3PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00591% European (non-Finnish) · 69/1,166,534 alleles
Filtering AF 0.00475% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00436%
Overall 0.00564% 89/1,576,756 alleles · very rare exomes 86/1,424,528 · genomes 3/152,228 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0212% 4,716
European (non-Finnish)grpmax 0.00591% 16,906
South Asian 0.0046% 21,754
East Asian 0.00233% 42,958
Admixed American 0.00179% 55,958
African / African-American 0.00135% 74,228

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
INTS1
Protein
p.Glu1742Lys
Coding
c.5224G>A
MANE Select
NM_001080453
dbSNP
rs371534075
Type
single nucleotide variant
Location
chr7:1476383 (GRCh38)
Gene constraint
LOEUF 0.785 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 75.49 · 8 PDB
Residue 1742
an α-helix
Full INTS1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ints1-p-glu1742lys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown